At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
LOGIQ P6 Diagnostic Ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Ultrasound for Measuring Fat of the Body
In Brief
A clinical study evaluating LOGIQ P6 Diagnostic Ultrasound for Subcutaneous Fat. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study is to provide information about human subcutaneous fat thickness at different anatomic sites on the body by measuring these thicknesses with a diagnostic ultrasound and also by correlating patient perceptions of body image with measured fat distribution. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubcutaneous Fat
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartMar 2019
Primary CompletionOct 2022
TodayJul 2026
First PostedMar 12, 2019
Enrollment StartMar 20, 2019
Primary CompletionOct 2, 2022
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.3 years ago
Interventions
LOGIQ P6 Diagnostic Ultrasoundother
Ultrasound measurements of subcutaneous fat thickness